'Medicaid best price' changes aimed at value-based gene therapy contracts -U.S. agency
Proposed changes to requirements that state-run Medicaid programs are given the best drug prices would clear the way for commercial health insurers to enter into "value-based" payment schemes, the U.S. Centers for Medicare & Medicaid Services said on Wednesday. [Source]
Publication Date:Origin: reuters.com
Category: companyNews
Topics: changes, Services, & Medicaid, Medicare, Centers, schemes, payment, into "value-based", enter, insurers, health, commercial, would clear, prices, given, programs, Medicaid, that state-run, requirements, Proposed, agency, contracts, therapy, value-based, aimed, price', 'Medicaid